Avalon GloboCare Provides Third Quarter 2018 Business Update; Reports 30% Increase in Revenues Nov 13, 2018
Avalon GloboCare Teams Up with Weill Cornell Medicine to Co-develop Standardization of cGMP-Grade Exosome Isolation and Application of Tissue-Specific Exosomes Oct 9, 2018
Avalon GloboCare Commences Operation of its Core GMP Platform, Epicon Biotech, to Facilitate Clinical Development of Cellular Therapies Sep 20, 2018
Avalon GloboCare Provides Second Quarter 2018 Business Update; Reports 32% Increase in Revenues Aug 15, 2018
Avalon GloboCare Appoints Dr. James L. Gajewski, Former Medical Director at M.D. Anderson Cancer Center, to Head Scientific and Clinical Advisory Board Aug 14, 2018
Avalon GloboCare Forms Strategic Partnership with Weill Cornell Medical College to Co-develop Technologies and Bio-production of CAR-T Therapy Aug 7, 2018
Avalon GloboCare Appoints Prominent Life Science M&A Attorney Steven Sanders to the Board of Directors Jul 31, 2018
Avalon GloboCare Announces Plans to Accelerate Commercialization of Proprietary CAR-T Technologies through Launch of Wholly Owned Subsidiary - Avactis Biosciences Jul 18, 2018
